Catalent Expands Integrated Softgel Operations
Catalent Pharma Solutions recently announced it will add new coating and blister packaging equipment at its 360,000-sq-ft, Eberbach, Germany, softgel manufacturing facility, expanding the integrated softgel solutions available. Coating services are expected to be operational in early 2015, with the packaging equipment expected to be online in the middle of the calendar year.
The new coating equipment, designed to coat softgels for controlled, enteric, and targeted release, will be capable of processing more than 300 million capsules per year and complements Catalent’s existing softgel coating capability at the company’s 78,000-sq-ft, Beinheim, France, facility. Catalent has conducted extensive studies to demonstrate the advantages of film coating softgels, including their physical stability protection under high storage temperatures and humidity.
“Providing an integrated service enhances process efficiency and control, and so improves supply lead time, potentially enabling our customers to reduce safety stock and extend product shelf life upon delivery,” said Dr. Richard Lackner, General Manager, Catalent Pharma Solutions, Eberbach.
As the originator of the RP Scherer softgel rotary die process, Catalent continues to innovate with new, breakthrough softgel technologies, such as OptiShell, a plant-derived capsule suitable for complex fill formulations, OptiGel Bio for macromolecules, and OptiGel Lock designed for abuse deterrence.
Catalent Pharma Solutions is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. For more information, visit www.catalent.com.
Total Page Views: 945
